semaglutide diabetes trial Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 at high cardiovascular risk treated with experience more stable kidney function compared with placebo Novo Nordisk's semaglutide shows promise

Shrinking follicles are a main reason for hair loss, because the follicle can no longer regrow lost hair

Estrogen influences where that fat sits and how readily it is released, which is why many women notice weight settling around the hips and thighs earlier in life, then migrating toward the midsection as hormone levels change

What's it going to do to me after 40 years of taking it

Peptide Therapy Stacked With Tesamorelin / Ipamorelin Tesamorelin / Ipamorelin is rarely the whole protocol

NICE guidance now recommends early consideration of SGLT2 inhibitors for people with established cardiovascular disease, heart failure, or chronic kidney disease

Food and Drug Administration is cracking down on telehealth companies for making false and misleading claims about compounded versions of popular weight loss drugs, GLP-1s